Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Weiyi Peng

1-14 of 14 results

Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

scientific article published on 8 December 2015

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

scientific article published on 05 April 2018

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

scientific article published on 6 September 2017

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer

scientific article published on 22 February 2019

The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.

scientific article published on 18 December 2017

The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression

scientific article published in March 2018

A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes

scientific article published on 2 August 2017

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma

scientific article published on 11 December 2018

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature

scientific article published on 12 September 2019

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

scientific article published on 22 August 2019

The glutaminase inhibitor CB-839 (Telaglenastat) enhances the anti-melanoma activity of T cell mediated immunotherapies

scientific article published on 23 December 2020

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

scientific article published on 29 October 2020

Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors

scientific article published on 02 March 2022

9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy

scientific article published on 23 September 2021